19/06/2026
๐ข Sonography Made Easy (SME)
๐ Planning to work in Saudi Arabia as an Allied Health Professional?
Join our upcoming Informative & Introductory Session designed for:
โ๏ธ Radiographers
โ๏ธ Ultrasound Technologists / Sonographers
โ๏ธ Other Allied Health Professionals
Topics We Will Cover
โ
SCFHS Licensing Process
โ
Documentation & DataFlow Requirements
โ
Exam Preparation Tips & Strategies
โ
Scope and Career Opportunities in KSA
โ
Common Mistakes to Avoid During Licensing
โ
Guidance from Professionals with Saudi Healthcare Experience
Whether you are a fresh graduate or an experienced professional, this session will help you understand the complete pathway to obtaining your Saudi professional license and starting your career in the Kingdom of Saudi Arabia.
๐ Interested in joining? Comment "Interested" below and we will send you the group link.
๐ Contact: +92 348 1315526
๐ง Email: [email protected]
Sonography Made Easy (SME)
Making your Saudi healthcare career journey easier, one step at a time. ๐ธ๐ฆ๐ฅ
16/06/2026
Preparing for the Saudi Commission for Health Specialties (SCFHS) Exam?
Many candidates donโt fail because the content is impossibleโthey struggle because their preparation isnโt structured or exam-focused.
What actually matters in your preparation:
โข High-yield topics (not everything in the syllabus)
โข Exam-oriented MCQs practice
โข Smart revision strategy
โข Time management under exam conditions
โข Understanding question patterns
The SCFHS exam is not just about knowledgeโitโs about applying it under pressure. A focused plan makes a real difference.
I guide healthcare professionals through SCFHS exam preparation with structured study plans, targeted resources, and practical exam strategies.
If youโre preparing for SCFHS and want a clear direction, feel free to reach out.
Join our group:
https://chat.whatsapp.com/Ltd4hdrBRgC9aUBpg2kHWa?s=cl&p=a&ilr=2
16/05/2026
Important Radiology Signs
16/05/2026
๐ฃ๐๐ข๐ฆ ๐ถ๐ ๐ก๐ผ๐ ๐ฃ๐ ๐ข๐ฆ
Polycystic O***y Syndrome (PCOS) has long been one of the most common hormonal conditions in women, affecting over 170 million people worldwide. But despite how widely used the term became, experts now say it was misleading in how it described the disease.
A new name has now been introduced: Polyendocrine Metabolic Ovarian Syndrome (PMOS).
This update, published in The Lancet and supported by international medical organizations and U.S. academic leaders (including experts from CU Anschutz), is being described as a major correction in how the condition is understood.
๐ช๐ต๐ ๐๐ต๐ฒ ๐ผ๐น๐ฑ ๐ป๐ฎ๐บ๐ฒ ๐๐ฎ๐ ๐บ๐ถ๐๐น๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ด:
The term โpolycystic o***y syndromeโ implied that the condition:
๐น was mainly an ovarian problem
๐น was defined by ovarian cysts
But modern evidence shows this is not accurate.
In reality:
๐น many patients have no ovarian cysts at all
๐น some are told their ultrasound is normal despite clear symptoms
๐น what is often seen on scans are immature follicles, not true cysts
Over time, this misunderstanding narrowed medical focus to the ovaries, leading to:
๐น delayed diagnosis
๐น overemphasis on reproductive issues
๐น under-recognition of broader health effects
๐ช๐ต๐ฎ๐ ๐ฃ๐ ๐ข๐ฆ ๐ฎ๐ฐ๐๐๐ฎ๐น๐น๐ ๐ฟ๐ฒ๐ณ๐น๐ฒ๐ฐ๐๐:
The new name shifts focus to the full disease picture. PMOS is now understood as a multisystem disorder, involving:
๐นHormonal imbalance (polyendocrine dysfunction)
๐นMetabolic dysfunction (especially insulin resistance and weight changes)
๐นReproductive effects (irregular ovulation and infertility)
๐นSkin manifestations (acne, hirsutism)
๐นPsychological effects (anxiety, depression)
๐น Long-term cardiometabolic risks
๐ช๐ต๐ ๐ฒ๐
๐ฝ๐ฒ๐ฟ๐๐ ๐ฝ๐๐๐ต๐ฒ๐ฑ ๐ณ๐ผ๐ฟ ๐๐ต๐ฒ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ:
The change is the result of more than a decade of international collaboration involving clinicians, researchers, and patients.
Experts, including endocrinology leaders such as those at CU Anschutz and pediatric endocrinologist Melanie Cree, highlighted that:
๐นthe old term caused misunderstanding and stigma
๐นit contributed to missed or delayed diagnoses
๐นit particularly affected how fertility concerns were framed
Large global consultations, surveys, and workshops involving tens of thousands of responses repeatedly showed the same issue: the name did not reflect patient reality.
07/04/2026
๐ฃ๐ผ๐ฟ๐๐ฎ๐น ๐๐๐ฝ๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐ผ๐ป โ ๐ ๐๐ผ๐บ๐ฝ๐น๐ฒ๐๐ฒ, ๐ฃ๐ฟ๐ฎ๐ฐ๐๐ถ๐ฐ๐ฎ๐น ๐๐๐ถ๐ฑ๐ฒ:
Portal hypertension refers to an increase in pressure within the portal venous system.
Under normal conditions, portal venous blood flows smoothly through the liver sinusoids into the hepatic veins.
When resistance increasesโmost commonly due to cirrhosisโthe system becomes congested. Pressure builds up, flow slows down, and eventually reverses.
To compensate, the body opens collateral channels to bypass the liver. These collaterals define advanced disease.
๐นCauses: Think in Three Levels
1. Prehepatic
Obstruction before blood reaches the liver:
โข Portal vein thrombosis
โข External compression (tumor, lymph nodes)
โข Congenital narrowing
โข Arteriovenous fistula
2. Intrahepatic (Most Common)
โข Cirrhosis (leading cause)
โข Chronic viral hepatitis
โข Schistosomiasis
โข Fibrosis and infiltrative diseases
3. Posthepatic
Obstruction after the liver:
โข BuddโChiari syndrome
โข Right heart failure (CCF)
โข Constrictive pericarditis
โข Sinusoidal obstruction
๐นUltrasound Evaluation
Liver:
โข Coarse echotexture
โข Irregular or nodular surface
โข Reduced size in advanced disease
These findings reflect chronic liver damage and increased resistance.
Portal Vein:
Diameter >13 mm (supportive, not diagnostic alone)
Spleen:
Splenomegaly (>13 cm)
Due to back pressure in the portal system
Ascites:
Free intraperitoneal fluid
Result of increased hydrostatic pressure and reduced oncotic pressure
๐นDoppler Findings (Core of Diagnosis)
1. Flow Direction
Normal: Hepatopetal (towards liver)
Abnormal: Hepatofugal (away from liver)
Reversed flow is a strong indicator of advanced portal hypertension.
2. Flow Velocity
Normal: 20โ40 cm/s
Portal hypertension: